Cancer Control and Population Sciences Home
Applied Research
Ductal Carcinoma in Situ Research Resources
Funded DCIS Projects:
Search:
A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)
Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer
Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ
Celecoxib in Preventing Breast Cancer in Premenopausal Women
Chemoprevention Trial -- Anastrozole in DCIS in Postmenopausal Women
Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer
Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy
Exemestane in Treating Postmenopausal Women at High Risk for Invasive Breast Cancer
Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions
Hypericum Perforatum (St. John's Wort) in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer
Incidence of Carcinoma, Ductal Carcinoma In Situ (DCIS), or Atypical Ductal Hyperplasia (ADH) in Patients With Lobular Neoplasia of the Breast
Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
Interstitial Brachytherapy Alone Versus External Beam Radiation Therapy After Breast Conserving Surgery for Low-Risk Invasive Carcinoma and Low-Risk Ductal Carcinoma in Situ (DCIS) of the Female Breast
Intraoperative Use of the BP Device for Detecting Positive Margins During Lumpectomy Procedure
Letrozole in Preventing Breast Cancer in Postmenopausal Women
Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer
Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast
Phase II Multicatheter HDR Breast Brachytherapy
Phase II Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer
Radiation Doses and Fractionation Schedules in Non-Low Risk Ductal Carcinoma In Situ (DCIS) of the Breast
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Radiofrequency Ablation Followed By Surgery in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ
RAPID: Randomized Trial of Accelerated Partial Breast Irradiation
Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS
Simvastatin and Anastrozole in Treating Postmenopausal Women With Invasive Breast Cancer, Ductal Carcinoma In Situ, or a High Risk of Breast Cancer
Simvastatin in Preventing a New Breast Cancer in Women Who Are at High Risk for a New Breast Cancer After Undergoing Surgery for Ductal Carcinoma in Situ or Stage I, Stage II, or Stage III Breast Cancer
Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With Active Breathing Coordinator
Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast
Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer
